Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers
Helena C. Bartels(University College Dublin), Donal J. Brennan(Mater Misericordiae University Hospital), Paul Downey(National Maternity Hospital), James D. Postle(National Maternity Hospital)
Cited by 244
Related Papers
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
Serum kreatininbestimmung ohne enteiweissen
|Clinica Chimica Acta|1972|799
Maternal outcomes and risk factors for COVID-19 severity among pregnant women
|Scientific Reports|2021|147
CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance
|Clinical Cancer Research|2006|138
Gas exchange in the pregnant uterus
|Physiological Reviews|1967|136